1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT,
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): JUNE 9, 1997 (JUNE 6, 1997)
NU-TECH BIO-MED, INC.
(Exact Name of Registrant as Specified in Charter)
DELAWARE 0-11772 25-1411971
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer
of Incorporation) Identification No.)
55 ACCESS ROAD
WARWICK, RHODE ISLAND 02886
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (401) 732-6520
2
INDEX TO CURRENT REPORT ON FORM 8-K
OF NU-TECH BIO-MED, INC.
JUNE 9, 1997
ITEM PAGE
- ---- ----
ITEM 5. OTHER EVENTS 3
ITEM 7. EXHIBITS 3
SIGNATURES 4
-2-
3
ITEM 5. OTHER EVENTS.
Nu-Tech Bio-Med, Inc. (the "Company") has entered into an Amended and
Restated Employment Agreement (the "Restated Agreement") with J. Marvin
Feigenbaum, the Company's Chairman, President and Chief Executive Officer, dated
June 6, 1997. The Restated Agreement amends and extends Mr. Feigenbaum's
original employment agreement with the Company, dated June 1, 1994, as amended.
The Restated Agreement is effective as of May 12, 1997 and expires May 11, 2000.
The Restated Agreement provides for Mr. Feigenbaum's continued employment as
Chairman of the Board, President and Chief Executive Officer of the Company, as
well as Mr. Feigenbaum's continued employment as Chief Executive and Chief
Financial Officer of Analytical Biosystems Corp., a wholly-owned subsidiary of
the Company. The Restated Agreement allows for Mr. Feigenbaum's contemporaneous
employment as Chairman, President and Chief Executive Officer of Physicians
Clinical Laboratory, Inc. ("PCL"). Pursuant to the Restated Agreement, the
Company has agreed to pay Mr. Feigenbaum a base salary of $208,000 per year
(such amount does not include any compensation from PCL). In addition, the
Restated Agreement provides for vacation benefits, life insurance, an automobile
allowance, living expenses and travel and entertainment expenses. The Restated
Agreement further contains provisions for termination of the Restated Agreement
by mutual consent, for cause, without cause by the Company, for death or
disability of Mr. Feigenbaum and for good reason by Mr. Feigenbaum, as well as
provisions regarding the failure of the parties to renew the Restated Agreement
for an additional term and the change of control of the Company. The foregoing
does not purport to be a complete description of the Restated Agreement and
reference is made to the Restated Agreement filed as an exhibit hereto for all
of its terms and conditions.
ITEM 7. EXHIBITS.
EXHIBIT NO. DOCUMENT
- ----------- --------
10 Amended and Restated Employment Agreement by and between the Company
and J. Marvin Feigenbaum, dated June 6, 1997
-3-
4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NU-TECH BIO-MED, INC.
By: /s/ J. Marvin Feigenbaum
------------------------------
Name: J. Marvin Feigenbaum
Title: Chairman and President
Date: June 9, 1997
-4-
5
EXHIBIT INDEX
EXHIBIT NO. DOCUMENT
- ----------- --------
10 Amended and Restated Employment Agreement by and between the Company
and J. Marvin Feigenbaum, dated June 6, 1997